Trial NCT00687674

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000597065
Secondary IDs: 07-006234 MC078A NCI-2009-01284 P30CA015083 RV-MM-PI-0142 SR06-933

Last trial update was posted on 2019-08-20

MeSH Interventions

Dexamethasone Lenalidomide Sorafenib

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell Plasmacytoma

Other Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Stopping Reasons

Due to study design (and toxicity), this trial closed to accrual prior to opening the phase II portion.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID